Kai M, Hikita H, Kazuki M, Tahata Y, et al. Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study. PLoS One 2024;19:e0294590.
PMID: 38165900